Related references
Note: Only part of the references are listed.Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs
David L. Mack et al.
MOLECULAR THERAPY (2017)
Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice
Hichem Tasfaout et al.
NATURE COMMUNICATIONS (2017)
PIK3C2B inhibition improves function and prolongs survival in rnyotubular myopathy animal models
Nesrin Sabha et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Skeletal Muscle Pathology in X-Linked Myotubular Myopathy: Review With Cross-Species Comparisons
Michael W. Lawlor et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2016)
Analysis of protein-coding genetic variation in 60,706 humans
Monkol Lek et al.
NATURE (2016)
A global reference for human genetic variation
David M. Altshuler et al.
NATURE (2015)
Reducing dynamin 2 expression rescues X-linked centronuclear myopathy
Belinda S. Cowling et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
MutationTaster2: mutation prediction for the deep-sequencing age
Jana Marie Schwarz et al.
NATURE METHODS (2014)
Gene Therapy Prolongs Survival and Restores Function in Murine and Canine Models of Myotubular Myopathy
Martin K. Childers et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Innovative research methods for studying treatments for rare diseases: methodological review
Joshua J. Gagne et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Expanding the MTM1 mutational spectrum: novel variants including the first multi-exonic duplication and development of a locus-specific database
Jorge Oliveira et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2013)
Polyhydramnios: Causes, Diagnosis and Therapy
A. Hamza et al.
GEBURTSHILFE UND FRAUENHEILKUNDE (2013)
Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy
Michael W. Lawlor et al.
HUMAN MOLECULAR GENETICS (2013)
Large duplication in MTM1 associated with myotubular myopathy
K. Amburgey et al.
NEUROMUSCULAR DISORDERS (2013)
Clinical utility gene card for: Centronuclear and myotubular myopathies
Valerie Biancalana et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2012)
THIN RIBS ON CHEST X-RAY; A USEFUL SIGN IN THE DIFFERENTIAL DIAGNOSIS OF THE FLOPPY NEWBORN
John P. Osborne et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2010)
MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers
Alan H. Beggs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis
Anna Buj-Bello et al.
HUMAN MOLECULAR GENETICS (2008)
Centronuclear (myotubular) myopathy
Heinz Jungbluth et al.
ORPHANET JOURNAL OF RARE DISEASES (2008)
Myofiber size correlates with MTM1 mutation type and outcome in X-linked myotubular myopathy
Christopher R. Pierson et al.
NEUROMUSCULAR DISORDERS (2007)
A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease
Priya S. Kishnani et al.
JOURNAL OF PEDIATRICS (2006)
X-linked myotubular and centronuclear myopathies
CR Pierson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
Genotype-phenotype correlations in X-linked myotubular myopathy
M McEntagart et al.
NEUROMUSCULAR DISORDERS (2002)
Characterization of mutations in fifty North American patients with X-linked myotubular myopathy
GE Herman et al.
HUMAN MUTATION (2002)
The myotubularin family: from genetic disease to phosphoinositide metabolism
J Laporte et al.
TRENDS IN GENETICS (2001)
Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway
F Blondeau et al.
HUMAN MOLECULAR GENETICS (2000)
Share Paper
